What is Thermo Fisher Scientific Inc (TMO)?
Thermo Fisher Scientific Inc trades as TMO on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-11-06.
Is TMO in a Closelooknet index?
Not currently — Thermo Fisher Scientific Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-06.
Where does TMO trade against its moving averages?
Thermo Fisher Scientific Inc trades 2.6% above its 50-day and 22.5% above its 200-day moving average (1.2% below its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How does Thermo Fisher Scientific Inc compare with its peers?
Against its peer group (Diagnostics & Research · United States), Thermo Fisher Scientific Inc (TMO) sits 4.9% below its 52-week high, 2.6% above its 50-day average; Labcorp Holdings Inc. (LH) is 2.7% below, Qiagen NV (QGEN) is 12.0% below, Mettler-Toledo International Inc (MTD) is 4.6% below, as of 2026-11-05. Put any of them next to TMO in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
How does Thermo Fisher Scientific Inc trade when bond yields rise?
Over the past year Thermo Fisher Scientific Inc had a beta of 0.50 to TLT, the long-dated Treasury fund — it tends to move with bonds, higher than 45% of US names. On the 10 sessions in which long bonds fell most it moved −0.15% on average, against −0.74% for the S&P 500. As of 2026-11-05; The "How it trades on rate days" block on this page carries the lines.
What does Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific supplies the instruments, reagents, consumables and services that laboratories use to run life-science research, diagnostics and drug manufacturing. It works through four segments: life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products with biopharma services. Customers include drugmakers, hospitals, academic labs and government researchers. Closelooknet has not placed it in a peer group; the name the market most often compares it with is Danaher, which spans similar life-sciences and diagnostics instrumentation. (Company snapshot of 2026-09-17.)
Where does Thermo Fisher Scientific Inc sit in the AI build-out?
Thermo Fisher sits outside our index seats; it belongs to the healthcare and life-sciences tools sleeve of our universe rather than to a build-out layer such as chips or data centres. It is a supplier of laboratory equipment and reagents to biotech and diagnostics customers, not a constituent of the AI stack the diary tracks elsewhere. It carries an S&P 500 seat but no Rubin or Halo placement, and it does not yet carry a Closelooknet score; the readings the diary notes are a chart move above its 50- and 200-day levels and a broker downgrade to Underperform. (Company snapshot of 2026-09-17.)
Does Thermo Fisher Scientific Inc pay a dividend?
Thermo Fisher Scientific Inc has paid 1.84 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.27% on the 2026-11-05 close; the last distribution recorded in the price series was 0.47 USD on 2026-09-15. As of 2026-11-05; the "Dividends and capital return" block on this page carries the lines.
What has Wall Street done on Thermo Fisher Scientific Inc recently?
The most recent analyst action on Thermo Fisher Scientific Inc on the Closelooknet wire is a price target by Argus on 2026-10-30 (target 780). 4 actions on the analyst wire since 2026-08-13: 1 downgrade, 3 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.
What does this page show?
A live price chart with SMA overlays and drawing tools for TMO, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.